Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

In-silico studies, synthesis, and pharmacological screening of novel multitarget diphenylpyrazole scaffold as EGFR/BRAF and cyclooxygenase-2 inhibitors

scientific reports | Vol. 16 | 2025

DOI: https://doi.org/10.1038/s41598-025-33006-6

In-silico studies, synthesis, and pharmacological screening of novel multitarget diphenylpyrazole scaffold as EGFR/BRAF and cyclooxygenase-2 inhibitors

scientific reports | Vol. 16 | Issue 1973 | 2025

DOI: https://doi.org/10.1038/s41598-025-33006-6

In Vitro and In Vivo Appraisal of Glycerylmonostearate/chitosan Hybrid Nanocapsules As Peroral Delivery System of Simvastatin

AAPS | Vol. 26 | Issue 5 | 2025

DOI: https://doi.org/10.1208/s12249-025-03135-2

In Vitro and In Vivo Appraisal of Glycerylmonostearate/chitosan Hybrid Nanocapsules As Peroral Delivery System of Simvastatin

AAPS PharmSciTech | Vol. 26 | Issue 5 | 2025

DOI: https://doi.org/10.1208/s12249-025-03135-2

In Vitro and In Vivo Appraisal of Glycerylmonostearate/chitosan Hybrid Nanocapsules As Peroral Delivery System of Simvastatin

AAPS PharmSciTech | Vol. 26 | Issue 5 | 2025

DOI: https://doi.org/10.1208/s12249-025-03135-2

Identification of Bacterial Oligopeptidase B Inhibitors from Microbial Natural Products: Molecular Insights, Docking Studies, MD Simulations, and ADMET Predictions

Pharmaceuticals | Vol. 18 | Issue 5 | 2025

DOI: https://doi.org/10.3390/ph18050709

Intranasal trimethyl chitosan-coated emulsomes containing tizanidine as brain-targeted therapy in spasticity: formulation, optimization, and pharmacokinetic assessment

Drug Delivery and Translational Research | 2024

DOI: https://doi.org/10.1007/s13346-024-01753-0

Intranasal nanotransferosomal gel for quercetin brain targeting: II. Antidepressant effect in an experimental animal model

MDPI-Pharmaceutics | Vol. 15 | Issue 8 | 2023

DOI: https://doi.org/10.3390/pharmaceutics15082095

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model

Pharmaceutics | 2023

DOI: https://doi.org/10.3390/pharmaceutics15082095

Intranasal nanotransferosomal gel for quercetin brain targeting: I. optimization, characterization, brain localization, and cytotoxic studies

MDPI-Pharmaceutics | Vol. 7 | Issue 15 | 2023

DOI: https://doi.org/10.3390/pharmaceutics15071805

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies

Pharmaceutics | 2023

DOI: https://doi.org/10.3390/pharmaceutics15071805

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies

Pharmaceutics | Vol. 15 | Issue 7 | 2023

DOI: https://doi.org/10.3390/pharmaceutics15071805

In Vitro and In Vivo Characterization Methods for Evaluation of Modern Wound Dressings

Pharmaceutics | Vol. 15 | Issue 1 | 2023

DOI: https://doi.org/10.3390/pharmaceutics15010042

Improved antibacterial activity of sulfasalazine loaded fullerene derivative: computational and experimental studies

Journal of Molecular Liquids | Vol. 348 | 2022

DOI: https://doi.org/10.1016/j.molliq.2021.118083

Impact of highly phospholipid-containing lipid nanocarriers on oral bioavailability and pharmacodynamics performance of genistein

Pharmaceutical Development and Technology | 2022

DOI: https://doi.org/10.1080/10837450.2022.2076111

Innovative pulmonary targeting of terbutaline sulfate-laded novasomes for non-invasive tackling of asthma: statistical optimization and comparative in vitro/in vivo evaluation

Drug Delivery | 2022

DOI: https://doi.org/10.1080/10717544.2022.2092236

Intranasal delivery of granisetron to the brain via nanostructured cubosomes-based in situ gel for improved management of chemotherapy-induced emesis

Pharmaceutics | 2022

DOI: https://doi.org/10.3390/pharmaceutics14071374

Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation

Journal of Drug Delivery Science and Technology | Vol. 67 | 2022

DOI: https://doi.org/10.1016/j.jddst.2021.102939

In Vitro Anti-Proliferative, and Kinase Inhibitory Activity of Phenanthroindolizidine Alkaloids Isolated from Tylophora indica

Plants | Vol. 11 | Issue 10 | 2022

DOI: https://doi.org/10.3390/plants11101295

Impact of highly phospholipid-containing lipid nanocarriers on oral bioavailability and pharmacodynamics performance of genistein

Pharmaceutical Development and Technology | Vol. 27 | Issue 4 | 2022

DOI: https://doi.org/10.1080/10837450.2022.2076111

Impact of highly phospholipid-containing lipid nanocarriers on oral bioavailability and pharmacodynamics performance of genistein

Pharmaceutical Development and Technology | 2022

DOI: https://doi.org/10.1080/10837450.2022.2076111

In vitro release and cytotoxicity study of encapsulated sulfasalazine within LTSP micellar/ liposomal and TSP micellar/niosomal nano-formulations

Alexandria Engineering Journal | Vol. 61 | Issue 12 | 2022

DOI: https://doi.org/10.1016/j.aej.2022.02.019

Intratracheally Inhalable Nifedipine-Loaded Chitosan-PLGA Nanocomposites as a Promising Nanoplatform for Lung Targeting: Snowballed Protection via Regulation of TGF-β/β-Catenin Pathway in Bleomycin-Induced Pulmonary Fibrosis

Pharmaceuticals | 2021

DOI: https://doi.org/10.3390/ph14121225

Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies

International Journal of Pharmaceutics | Vol. 572 | Issue 118781 | 2019

DOI: https://doi.org/10.1016/j.ijpharm.2019.118781

Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies

International journal of pharmaceutics | 2019

DOI: https://doi.org/10.1016/j.ijpharm.2019.118781